13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q1 2021. See the latest, Q3 2026 →
Reported value
$12.56B
+16% on the quarter before
Positions
59
27 new, 13 sold out
Top 10
64.8%
of the value
Est. gain
+$1.10B
on stocks held all quarter
Est. return
+12.4%
on those stocks since Q4 2020
Positions as of Mar 31, 2021, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2020. Striped tiles are options.
Largest buys
Since Q4 2020, sized at quarter-end prices.
- Willis Towers Watson Plc Ltd~$572.2MNew, 0.0% → 4.6% of the portfolio+2,500,000 shares
- Alphabet~$437.2MAdded, 1.3% → 4.8% of the portfolio+211,350 shares
- Intel~$327.7MAdded, 8.4% → 11.9% of the portfolio+5,119,765 shares
- International Flavors&Fragra~$293.2MNew, 0.0% → 2.3% of the portfolio+2,100,000 shares
- Qorvo~$143.3MAdded, 6.8% → 7.6% of the portfolio+784,371 shares
- Meta~$111.0MAdded, 2.3% → 3.0% of the portfolio+377,000 shares
- Nuvation Bio Inc~$82.4MNew, 0.0% → 0.7% of the portfolio+8,623,021 shares
- Cullinan Oncology Inc~$71.7MNew, 0.0% → 0.6% of the portfolio+1,835,560 shares
- Reinvent Technology Partners~$60.2MNew, 0.0% → 0.5% of the portfolio+6,000,000 shares
- Ajax I~$51.3MNew, 0.0% → 0.4% of the portfolio+5,000,000 shares
Largest sells
Since Q4 2020, sized at quarter-end prices.
- Ebay Inc.~$783.3MCut, 14.4% → 8.9% of the portfolio−12,790,800 shares
- Fox Corp~$526.3MCut, 6.0% → 2.2% of the portfolio−14,576,132 shares
- Marathon Pete Corp~$318.1MSold out, 2.9% → 0.0% of the portfolio−7,690,721 shares
- Viacomcbs Inc~$175.1MSold out, 1.6% → 0.0% of the portfolio−4,700,000 shares
- Ajax I~$62.0MSold out, 0.6% → 0.0% of the portfolio−5,000,000 shares
- Redball Acquisition Corp~$53.9MSold out, 0.5% → 0.0% of the portfolio−4,950,000 shares
- Vesper Healthcare Acqstn Cor~$44.8MSold out, 0.4% → 0.0% of the portfolio−3,960,000 shares
- Avanti Acquisition Corp~$43.4MSold out, 0.4% → 0.0% of the portfolio−4,000,000 shares
- Reinvent Technology Partners~$42.9MSold out, 0.4% → 0.0% of the portfolio−3,500,000 shares
- Horizon Acquisition Corporat~$37.6MSold out, 0.3% → 0.0% of the portfolio−3,500,000 shares
Holdings
As of Mar 31, 2021; changes in shares since Dec 31, 2020.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| IntelCOM · shares +28% · price +28.5% | 11.9% | $1.49B | +$257.9M | ||||||
| Liberty Global PlcSHS CL C · shares 0% · price +8.0% | 11.1% | $1.39B | +$103.1M | ||||||
| Ebay Inc.COM · shares −41% · price +21.9% | 8.9% | $1.12B | +$201.4M | ||||||
| QorvoCOM · shares +18% · price +9.9% | 7.6% | $954.5M | +$73.0M | ||||||
| Viasat IncCOM · shares 0% · price +47.2% | 6.2% | $783.0M | +$251.2M | ||||||
| AlphabetCAP STK CL C · shares +266% · price +18.1% | 4.8% | $601.8M | +$25.2M | ||||||
| Willis Towers Watson Plc LtdSHS · shares New | 4.6% | $572.2M | — | ||||||
| MicronCOM · shares +3.9% · price +17.3% | 3.8% | $478.4M | +$68.0M | ||||||
| MetaCL A · shares +41% · price +7.8% | 3.0% | $382.0M | +$19.7M | ||||||
| Pg&E CorpCOM · shares 0% · price −6.0% | 2.9% | $359.0M | −$23.0M | ||||||
| Pershing Square Tontine HldgCOM CL A · shares 0% · price −13.4% | 2.4% | $305.1M | −$47.1M | ||||||
| Translate Bio IncCOM · shares 0% · price −9.3% | 2.4% | $295.8M | −$30.4M | ||||||
| International Flavors&FragraCOM · shares New | 2.3% | $293.2M | — | ||||||
| Nexstar Media Group IncCL A · shares 0% · price +28.6% | 2.3% | $292.8M | +$65.1M | ||||||
| Liberty Media Corp DelCOM C SIRIUSXM · shares 0% · price +1.4% | 2.3% | $286.0M | +$3.9M | ||||||
| Fox CorpCL A COM · shares −66% · price +24.0% | 2.2% | $274.8M | +$53.2M | ||||||
| Ss&C Technologies Hldgs IncCOM · shares +15% · price −4.0% | 2.1% | $266.0M | −$9.5M | ||||||
| Fox CorpCL B COM · shares 0% · price +20.9% | 1.6% | $198.4M | +$34.4M | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price +5.9% | 1.6% | $196.5M | +$11.0M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price +14.9% | 1.4% | $178.3M | +$23.1M | ||||||
| Healthpeak Properties IncCOM · shares +24% · price +5.0% | 1.3% | $157.7M | +$6.0M | ||||||
| Colony Cap Inc NewCL A COM · shares 0% · price +34.7% | 1.2% | $156.9M | +$40.4M | ||||||
| Liberty Media Corp DelCOM A SIRIUSXM · shares 0% · price +2.1% | 1.2% | $154.3M | +$3.1M | ||||||
| Veritiv CorpCOM · shares 0% · price +104.6% | 1.2% | $151.6M | +$77.5M | ||||||
| Advantage Solutions IncCOM CL A · shares 0% · price −10.9% | 1.1% | $143.6M | −$17.6M | ||||||
| Total 59 positions | 100% | $12.56B | +$1.10B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2020 to Q1 2021: 31 stocks held throughout, up $1.10B (+12.4%).
- Intel+$257.9M+28%
- Viasat Inc+$251.2M+47%
- Ebay Inc.+$201.4M+22%
- Liberty Global Plc+$103.1M+8%
- Veritiv Corp+$77.5M+105%
- Pg&E Corp−$23.0M−6%
- Translate Bio Inc−$30.4M−9%
- Atara Biotherapeutics Inc−$44.7M−27%
- Pershing Square Tontine Hldg−$47.1M−13%
- Verint Sys Inc−$49.7M−32%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |